FULL SUPPLEMENT: Brodalumab: Five Years of Real-World Safety…
Emerging
2
Citations43
Refs2023
Year
Search Works
Work Details
- DOI 10.36849/jdd.sf378632
- OpenAlex ID W4387712597
- Type Article
- Language EN
- Published 01 Sep 2023
- Volume 22 (10)
- Pages SF378632s1–SF378632s16
- Source Journal of Drugs in Dermatology
- Publisher SanovaWorks
- FWCI 0.22
- Countries 1
- Institutions 2
- Added 18 Oct 2023
- Updated 14 Oct 2026
External Links
MENU
0
FULL SUPPLEMENT: Brodalumab: Five Years of Real-World Safety and Efficiency
Article 2023 EN Bronze
Psoriasis remains a highly prevalent condition in the United States and worldwide. Preclinical research has been triumphant in elucidating the critical immunological pathways involved in psoriasis. There has been an evolution in biologics that paralleled the understanding of these pathways beginning with anti-tumor necrosis factor (TNF) inhibitors and now most recently the interleukin (IL)-23 and…
2
Citations
43
References
2
Authors
0.22
FWCI
Citations by Year
Last 1 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
2 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Naiem Tony Issa | — | |
| 2 | Leon Kircik | DermResearch (United States) (US) Icahn School of Medicine at Mo… (US) |
Related Works
10Data: OpenAlex